12:00 AM
Dec 17, 2012
 |  BC Week In Review  |  Company News  |  Deals

Pharmascience, GlaxoSmithKline deal

Pharmascience and Human Genome Sciences Inc. mutually terminated a 2007 deal granting Human Genome ex-Japanese rights to HGS1029 ( AEG40826). Pharmascience, which regains worldwide rights to the small molecule antagonist...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >